CG
GHDX

Caprock Group’s Genomic Health, Inc. GHDX Stock Holding History

Caprock Group’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,538
Closed -$206K – 382
2019
Q2 		$206K Hold
3,538
– – 0.04% 309
2019
Q1 		$248K Sell
3,538
-195
-5% -$14.5K 0.05% 293
2018
Q4 		$240K Sell
3,733
-900
-19% -$63.1K 0.06% 281
2018
Q3 		$325K Hold
4,633
– – 0.07% 257
2018
Q2 		$234K Buy
+4,633
New +$184K 0.05% 348

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Caprock Group's GHDX Position: Q3 2019 in Review

Caprock Group sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 3,538 shares — an estimated $206K sold.

Caprock Group first reported a position in GHDX in Q2 2018 and held it in 5 quarters. The position peaked at $325K in Q3 2018. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Caprock Group reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Caprock Group sold 3,538 Genomic Health, Inc. shares in Q3 2019, an estimated $206K.
  • Caprock Group first reported a position in Genomic Health, Inc. in Q2 2018 and held it in 5 quarters.
  • Caprock Group's Genomic Health, Inc. position peaked at $325K in Q3 2018.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Caprock Group's 13F filing for Q3 2019, filed 31 Oct 2019.